Bolden Announces $1.5M Pre-Seed Financing
Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis…
MindImmune Appoints Industry Leaders to Board of Directors
Brad Margus and Robert Michael Poole, MD FACP, bring deep background and…
Slater to oversee $12M for Rhode Island venture development
By: Jacquelyn Voghel Published in Providence Business News Rhode Island's…
Rhode Island Commerce Awards Slater $12M for Venture Development
VC Firm Receives SSBCI Funding for Second Time Providence, R.I. – In…
Brown-launched biotech secures $375,000 in Slater funding
XM Therapeutics seeks to develop new treatments for chronic heart and pulmonary…
Slater Invests in XM Therapeutics from Brown University
Biotech Targeting Heart Failure and Pulmonary Fibrosis Comes out of Stealth…
Faculty inventions, startups shine at Innovation@Brown Showcase
As part of Rhode Island Startup Week, business leaders, investors and…
State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience
By: Jacquelyn Voghel Published in Providence Business News For the developers…
RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company
New Fund Participates in Series A Financing for URI-Based MindImmune, Developer…